BRPI1015145A2 - derivados de tiazol e seu uso como receptores antagonistas de p2y12 - Google Patents
derivados de tiazol e seu uso como receptores antagonistas de p2y12Info
- Publication number
- BRPI1015145A2 BRPI1015145A2 BRPI1015145A BRPI1015145A BRPI1015145A2 BR PI1015145 A2 BRPI1015145 A2 BR PI1015145A2 BR PI1015145 A BRPI1015145 A BR PI1015145A BR PI1015145 A BRPI1015145 A BR PI1015145A BR PI1015145 A2 BRPI1015145 A2 BR PI1015145A2
- Authority
- BR
- Brazil
- Prior art keywords
- thiazole derivatives
- antagonist receptors
- antagonist
- receptors
- thiazole
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 150000007979 thiazole derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2009051647 | 2009-04-22 | ||
| PCT/IB2010/051742 WO2010122504A1 (en) | 2009-04-22 | 2010-04-21 | Thiazole derivatives and their use as p2y12 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1015145A2 true BRPI1015145A2 (pt) | 2018-01-30 |
Family
ID=42261943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1015145A BRPI1015145A2 (pt) | 2009-04-22 | 2010-04-21 | derivados de tiazol e seu uso como receptores antagonistas de p2y12 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8664203B2 (pt) |
| EP (1) | EP2421859B1 (pt) |
| JP (1) | JP5536876B2 (pt) |
| KR (1) | KR101728180B1 (pt) |
| CN (1) | CN102405220B (pt) |
| AU (1) | AU2010240527A1 (pt) |
| BR (1) | BRPI1015145A2 (pt) |
| CA (1) | CA2756654C (pt) |
| ES (1) | ES2469847T3 (pt) |
| IL (1) | IL215690A0 (pt) |
| MA (1) | MA33277B1 (pt) |
| MX (1) | MX2011010811A (pt) |
| NZ (1) | NZ596388A (pt) |
| SG (1) | SG175297A1 (pt) |
| WO (1) | WO2010122504A1 (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200640877A (en) | 2005-04-28 | 2006-12-01 | Actelion Pharmaceuticals Ltd | Pyrimidine derivatives |
| CL2007002920A1 (es) | 2006-10-13 | 2008-06-06 | Actelion Pharmaceuticals Ltd | Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos. |
| AR063518A1 (es) | 2006-10-25 | 2009-01-28 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y su uso para tratar y/o prevenir enfermedades vasculares perifericas viscerales, hepaticas y renales, enfermedades cardiovasculares y enfermedades cerebrovasculares asociados con la agregacion de plaquetas, incluyendo trombosis |
| JP4729133B2 (ja) * | 2007-11-29 | 2011-07-20 | アクテリオン ファーマシューティカルズ リミテッド | ホスホン酸誘導体及びｐ２ｙ１２受容体拮抗剤としてのそれらの使用 |
| AR071653A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-4-ciclopropil-pirimidina |
| AR071652A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2- fenil-piridina substituidos |
| CA2756542C (en) | 2009-04-08 | 2017-08-22 | Actelion Pharmaceuticals Ltd | 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines |
| UY34832A (es) | 2012-05-31 | 2013-12-31 | Phenex Pharmaceuticals Ag | TIAZOLES SUSTITUIDOS POR CARBOXAMIDA O SULFONAMIDA Y DERIVADOS RELACIONADOS COMO MODULADORES PARA EL RECEPTOR NUCLEAR HUÉRFANO RORy (lambda) |
| DE102014108210A1 (de) | 2014-06-11 | 2015-12-17 | Dietrich Gulba | Rodentizid |
| DK3515924T3 (da) | 2016-09-22 | 2022-03-21 | Idorsia Pharmaceuticals Ltd | Krystallinske former |
| CN106831869A (zh) * | 2017-02-09 | 2017-06-13 | 广东赛博科技有限公司 | 胺基噻吩芳基氧化膦p2y12受体拮抗剂及其用途 |
| CN106831870A (zh) * | 2017-02-09 | 2017-06-13 | 广东赛博科技有限公司 | 一类腈基噻吩芳基氧化膦p2y12受体拮抗剂及其用途 |
| CN106831868A (zh) * | 2017-02-09 | 2017-06-13 | 广东赛博科技有限公司 | 一种胺基噻吩芳基氧化膦p2y12受体拮抗剂及其用途 |
| CN106831867A (zh) * | 2017-02-09 | 2017-06-13 | 广东赛博科技有限公司 | 一种腈基噻吩芳基氧化膦p2y12受体拮抗剂及其用途 |
| CN106749408A (zh) * | 2017-02-09 | 2017-05-31 | 广东赛博科技有限公司 | 一种硝基噻吩芳基氧化膦p2y12受体拮抗剂及其用途 |
| CN106831866A (zh) * | 2017-02-09 | 2017-06-13 | 广东赛博科技有限公司 | 一类烷氧噻吩芳基氧化膦p2y12受体拮抗剂及其用途 |
| CN106831871A (zh) * | 2017-02-09 | 2017-06-13 | 广东赛博科技有限公司 | 一类硝基噻吩芳基氧化膦p2y12受体拮抗剂及其用途 |
| SG11201908128YA (en) | 2017-03-15 | 2019-10-30 | Idorsia Pharmaceuticals Ltd | Subcutaneous administration of a p2y12 receptor antagonist |
| EP4070658A1 (de) | 2021-04-06 | 2022-10-12 | BIORoxx GmbH | Verwendung von blutgerinnungshemmenden verbindungen als rodentizide |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6861424B2 (en) | 2001-06-06 | 2005-03-01 | Schering Aktiengesellschaft | Platelet adenosine diphosphate receptor antagonists |
| EA200500899A1 (ru) | 2002-12-11 | 2006-02-24 | Шеринг Акциенгезельшафт | Антагонисты аденозиндифосфатного рецептора тромбоцитов |
| US7056889B2 (en) * | 2002-12-16 | 2006-06-06 | Kimberly-Clark, Worldwide, Inc. | Compounds that bind P2Y2 or P2Y1 receptors |
| TW200640877A (en) * | 2005-04-28 | 2006-12-01 | Actelion Pharmaceuticals Ltd | Pyrimidine derivatives |
| TWI382976B (zh) | 2005-10-21 | 2013-01-21 | Actelion Pharmaceuticals Ltd | 作為抗瘧疾劑之新穎哌 |
| TWI391378B (zh) * | 2006-03-16 | 2013-04-01 | Astellas Pharma Inc | 喹啉酮衍生物或其製藥學上可被容許之鹽 |
| CL2007002920A1 (es) | 2006-10-13 | 2008-06-06 | Actelion Pharmaceuticals Ltd | Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos. |
| AR063518A1 (es) | 2006-10-25 | 2009-01-28 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y su uso para tratar y/o prevenir enfermedades vasculares perifericas viscerales, hepaticas y renales, enfermedades cardiovasculares y enfermedades cerebrovasculares asociados con la agregacion de plaquetas, incluyendo trombosis |
| WO2008128647A1 (en) | 2007-04-23 | 2008-10-30 | Sanofi-Aventis | Quinoline-carboxamide derivatives as p2y12 antagonists |
| AU2008266228A1 (en) * | 2007-06-13 | 2008-12-24 | Bristol-Myers Squibb Company | Dipeptide analogs as coagulation factor inhibitors |
| JP4729133B2 (ja) | 2007-11-29 | 2011-07-20 | アクテリオン ファーマシューティカルズ リミテッド | ホスホン酸誘導体及びｐ２ｙ１２受容体拮抗剤としてのそれらの使用 |
| EP2238127B1 (en) | 2007-12-26 | 2012-08-15 | Sanofi | Pyrazole-carboxamide derivatives as p2y12 antagonists |
| WO2009080226A2 (en) | 2007-12-26 | 2009-07-02 | Sanofis-Aventis | Heterocyclic pyrazole-carboxamides as p2y12 antagonists |
| AR071652A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2- fenil-piridina substituidos |
| AR071653A1 (es) | 2008-04-11 | 2010-07-07 | Actelion Pharmaceuticals Ltd | Derivados 2-fenil-4-ciclopropil-pirimidina |
| CA2756542C (en) | 2009-04-08 | 2017-08-22 | Actelion Pharmaceuticals Ltd | 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines |
-
2010
- 2010-04-21 CA CA2756654A patent/CA2756654C/en active Active
- 2010-04-21 SG SG2011077203A patent/SG175297A1/en unknown
- 2010-04-21 KR KR1020117026192A patent/KR101728180B1/ko not_active Expired - Fee Related
- 2010-04-21 MA MA34354A patent/MA33277B1/fr unknown
- 2010-04-21 US US13/265,493 patent/US8664203B2/en active Active
- 2010-04-21 JP JP2012506624A patent/JP5536876B2/ja not_active Expired - Fee Related
- 2010-04-21 ES ES10719097.7T patent/ES2469847T3/es active Active
- 2010-04-21 MX MX2011010811A patent/MX2011010811A/es not_active Application Discontinuation
- 2010-04-21 NZ NZ596388A patent/NZ596388A/xx not_active IP Right Cessation
- 2010-04-21 WO PCT/IB2010/051742 patent/WO2010122504A1/en not_active Ceased
- 2010-04-21 CN CN201080017552.3A patent/CN102405220B/zh not_active Expired - Fee Related
- 2010-04-21 AU AU2010240527A patent/AU2010240527A1/en not_active Abandoned
- 2010-04-21 BR BRPI1015145A patent/BRPI1015145A2/pt not_active IP Right Cessation
- 2010-04-21 EP EP10719097.7A patent/EP2421859B1/en active Active
-
2011
- 2011-10-11 IL IL215690A patent/IL215690A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR101728180B1 (ko) | 2017-04-18 |
| AU2010240527A1 (en) | 2011-12-01 |
| IL215690A0 (en) | 2012-01-31 |
| MA33277B1 (fr) | 2012-05-02 |
| NZ596388A (en) | 2013-05-31 |
| CA2756654C (en) | 2017-08-22 |
| CN102405220A (zh) | 2012-04-04 |
| SG175297A1 (en) | 2011-12-29 |
| EP2421859A1 (en) | 2012-02-29 |
| JP2012524774A (ja) | 2012-10-18 |
| CN102405220B (zh) | 2015-05-27 |
| WO2010122504A1 (en) | 2010-10-28 |
| MX2011010811A (es) | 2011-10-28 |
| CA2756654A1 (en) | 2010-10-28 |
| US8664203B2 (en) | 2014-03-04 |
| US20120053149A1 (en) | 2012-03-01 |
| US20130281406A2 (en) | 2013-10-24 |
| JP5536876B2 (ja) | 2014-07-02 |
| EP2421859B1 (en) | 2014-04-09 |
| ES2469847T3 (es) | 2014-06-20 |
| KR20120016626A (ko) | 2012-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1015145A2 (pt) | derivados de tiazol e seu uso como receptores antagonistas de p2y12 | |
| CY2023012I2 (el) | Παραγωγα κινολιν-8-σουλφοναμιδιου εχοντα αντικαρκινικη δραση | |
| BR112013016030A2 (pt) | compostos e seu uso como inibidores de bace | |
| BRPI0810462A2 (pt) | Derivados de quinolina-carboxamida como antagonistas de p2y12 | |
| BRPI0920448A2 (pt) | compostos spiro-oxindol e seu uso como agentes terapêuticos | |
| BRPI0908225A2 (pt) | derivados de piridazina e seu uso como agentes terapêuticos | |
| BR112013014314A2 (pt) | derivados de 6-amino-2-fenilamino-1h-benzimidazol-5-carboxamida e seu uso como inibidores de prostaglandina e2 sintase-1 microssômicas | |
| HRP20190016T1 (hr) | Heterociklički spojevi i njihova upotreba | |
| BRPI0814231A2 (pt) | Derivados de pleuromutilina e seu uso como antimicrobianos | |
| BRPI0913885A8 (pt) | tiadiazoliloxifenilamidinas e seu uso como fungicidas | |
| BRPI0817061A2 (pt) | Derivados de pirrolidinilalquilisoquinolinona e -isoindolinona como antagonistas de histamina-3 | |
| BR112012008044A2 (pt) | pteridinas e seu uso como agroquímicos | |
| BRPI1012333A2 (pt) | atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso | |
| BRPI1010533A2 (pt) | tetrahidroazolopirazinas sulfoniladas e seu uso como medicamentos | |
| BR112012024870A2 (pt) | derivados de 4-aminopirimidina e seus antagonistas do receptor a2a de adenosina | |
| BRPI0817245A2 (pt) | Derivados e quinolina como antagonistas receptores de 5ht5a | |
| BRPI0813831A2 (pt) | Compostos de heteroarila bicíclica e seu uso como inibidores de quinase | |
| PT3109248T (pt) | Derivados de heteroarilpiperidina e piperazina como fungicidas | |
| BRPI1008082A2 (pt) | Isotiazoliloxifenilamisinas e seu emprego como fungicidas | |
| PL2513093T3 (pl) | Nowi antagoniści receptora CCR2 i ich zastosowanie | |
| BRPI0720866A2 (pt) | Derivados de oxindol substituídos e seu uso como ligandos de receptor de vasopressina | |
| BRPI0816806A2 (pt) | Derivados de azaciclil-isoquinolinona e isoindolinona como antagonista de histamina-3 | |
| BR112013014725A2 (pt) | derivados estrigolactamasestrigolactama e seu uso como reguladores plantas | |
| BR112013004662A2 (pt) | agonistas de receptores de neurotrofina e o uso destes como medicamentos | |
| CU23857B1 (es) | Nuevos derivados de benzamida como antagonistas de la bradiquinina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |